Your shopping cart is empty!
Speaker: David Hoffmann. A review of the newly discovered endocannabinoid system, its pharmacology and therapeutic implications. Do these insights translate into medicinal uses for cannabis, and if so what indications can be legitimately defended?
0 reviews / Write a review
Speaker: Kevin Spelman. Continued from Part 1. Many healthcare providers are, unfortunately, un..
Speaker: Kevin Spelman. Many healthcare providers are, unfortunately, unaware of the effects of..
Speaker: Christopher Hobbs. Reviews over 250 clinical trials on the efficacy and safety of cann..
Speaker: Jonathan Treasure. The use of Cannabis to treat issues such as cancer pain or chemo-in..
Panelists: Paul Bergner, Jonathan Treasure and Kenneth Proefrock. While these drugs can have uninten..
Speaker: Paul Bergner. Heavy Cannabis use can have acute and chronic side effects, including a..
Speaker: Donald Yance. Part 2 continues describing targeted molecular pathways in cancer, such ..
Speaker: Donald Yance. Describes targeted molecular pathways in cancer, such as EGFR, HER2/neu,..
Speaker: Kevin Spelman. Reports in both the biomedical literature and from patients suggest tha..
Speaker: Kenneth Proefrock. Continued from Part 1 Kenneth Proefrock continues presenting his cl..
Speaker: Kenneth Proefrock. Kenneth Proefrock presents his clinical experience using Cann..
Speaker: Chris Kilham. The effects of mood-modifying and psychoactive plants from coffee and ch..
medical marijuana research,